Biden’s Plans to Reduce Cost of Medicare Drugs To Send Ripple Effects Through Nursing Home Industry
By Amy Stulick
Skilled Nursing News
Following the Biden Administration’s bid this week to reduce the price of certain drugs – many of which are commonly used in nursing homes – experts are cautioning that the changes may negatively impact the bottomline of organizations in the sector.
As Medicare Part D price negotiations for these drugs come into focus this week, the Senior Care Pharmacy Coalition (SCPC), for one, is warning that changes to Part D might cause “collateral damage” to long-term care pharmacies, the patients they serve and operator partners.
On Tuesday, federal policy makers released the names of the first 10 drugs approved to be part of Medicare’s first-ever price negotiations in order to further the goals of the Inflation Reduction Act.
Certain blood thinners, diabetes treatments and medications used for COPD, cancer, heart failure, cardiovascular disease and psoriatic arthritis covered under Medicare Part D will be under price negotiations starting on Jan. 1, 2026.
Such drugs have a high expenditure, and are single source drugs without generic or biosimilar competition. Many have been on the U.S. market for an average of 13 years, according to ATI Advisory.
“Long-term care patients and pharmacies will be severely and disproportionately impacted by these price negotiations, given that eight of the medications named by the Biden administration are heavily prescribed to patients in long-term care facilities,” Alan Rosenbloom, president and CEO of SCPC, said in a statement.
Read the full original article here.
Recent Posts
-
Op-Ed: Long-term care pharmacies need help to stay open
I’ve long been an advocate for growing our business community in a thoughtful and sustainable way. What’s often missing from the economic development conversation is health care. Access to affordable, reliable care isn’t just a quality-of-life issue — it’s a business issue. When workers are healthy and families can stay in their communities, employers can grow, jobs can be filled, and local economies thrive. In rural areas especially, a strong health care system is essential infrastructure for economic growth.
-
Letter to the Editor: Needs for LTC pharmacies must continue to be met
As a nurse anesthesiologist and owner of a nursing practice, I’ve come to really appreciate the collaborative ecosystem that is healthcare. Even something as simple as a prescription shows how interconnected our system is — you’ve got scientists developing treatments, providers making clinical decisions, and pharmacists making sure everything’s used properly, each bringing essential expertise to the table.
-
Rep. Buddy Carter Presses for Congressional Action on Long-Term Care Crisis During Energy and Commerce Legislative Hearing
During the Energy and Commerce Committee’s January 8 hearing, Legislative Proposals to Support Patient Access to Medicare Services, Rep. Buddy Carter (R-GA), an original co-sponsor of H.R. 5031, the Preserving Patient Access to Long-Term Care Pharmacies Act, underscored the urgent need for the Committee and Congress to advance this critical legislation to protect seniors’ access to […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.